Request for Information: Biomolecule Purification
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEF ADVANCED RESEARCH PROJECTS AGCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
DARPA-SN-26-66
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AC12
Additional Details
Documents2
The Defense Advanced Research Projects Agency (DARPA), through its Multi X Office (MXO), has issued a Special Notice (Procurement Identifier: DARPA-SN-26-66) seeking information on innovative methods for the purification of large, complex biomolecules. This Request for Information (RFI) is part of DARPA’s ongoing efforts to identify and develop transformative technologies that can address current limitations in biomolecule purification processes.
The primary objective of this RFI is to gather insights and technical approaches that could enable the creation of a universal purification platform. Such a platform would be capable of efficiently separating and recovering multiple large and complex molecules—including biologically produced proteins and other critical biomolecules—from complex feedstocks. The envisioned solution should deliver high specificity, purity, and yield, while significantly reducing the time and complexity associated with current purification methods. Notably, DARPA aims to move beyond the prevailing reliance on multistep chromatography, which is considered the current state of the art, by identifying novel approaches that could streamline or even eliminate these processes.
In addition to soliciting technical solutions, DARPA is interested in understanding the latest advances and persistent challenges in the purification of biologically produced molecules. The agency seeks information on both the technical hurdles and the potential operational capabilities that could be unlocked by next-generation purification technologies. The responses collected through this RFI will directly inform the development of a new DARPA program focused on advancing biomolecule purification.
This opportunity is classified under NAICS code 541715, which pertains to Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), and is further identified by Product Service Code AC12. The contracting entity is the Defense Advanced Research Projects Agency, a federal office within the Department of Defense.
Interested parties are encouraged to review the full notice and any associated attachments available on SAM.gov (Opportunity ID: b8e73bf9adcb4c62a0da544d64795ef9) for detailed submission instructions and requirements. The notice remains active, with a response deadline set for June 8, 2026, at 17:06. All inquiries and responses should be directed to the designated coordinator via email at [email protected].
This RFI represents a significant opportunity for organizations with expertise in biomolecule purification, process engineering, and related research and development fields to contribute to the next generation of purification technologies. Contractors considering a response should ensure their capabilities align with DARPA’s focus on innovative, high-impact solutions that can address the outlined objectives and deliverables.